OPKO Health, Inc. OPK Income Statement

Opko health, inc. (OPK)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenues:
Total revenues
890,950	901,935	899,443	920,486	957,803	990,266	929,397	925,622	954,538	966,006	976,345	1,028,340	1,092,839	1,117,494	1,222,363	1,067,362	752,691	491,738	241,080	117,819	98,935	91,125	86,284	87,152	87,428	96,530	92,099	83,253	69,643	47,044	36,577	31,589	29,806	27,979	27,863	28,511	0	0	0
License revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Costs and expenses:
Gross margin, excluding amortization of intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	11,430	11,245	0	0	0
Selling, general and administrative
324,279	343,305	359,278	362,807	361,985	358,346	359,171	378,277	396,203	414,628	355,674	377,342	389,274	407,331	473,304	403,705	307,131	196,576	108,873	67,637	61,574	57,940	58,141	57,703	56,708	55,320	50,242	43,992	35,548	27,795	22,494	19,520	18,785	19,169	18,543	19,839	0	0	0
Research and development
103,101	117,870	128,160	128,303	129,228	125,586	126,500	128,848	132,765	126,435	122,470	114,386	112,606	113,871	109,072	103,585	101,807	99,488	99,836	101,416	88,080	83,571	81,095	71,663	64,986	53,902	37,130	29,666	24,599	19,520	17,197	16,877	15,095	11,352	8,640	6,914	0	0	0
In-process research and development
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-
Contingent consideration
-20,520	-14,854	-4,488	-2,186	-13,769	-16,816	-11,353	-23,759	-4,035	-3,423	-3,126	11,180	17,572	16,954	14,182	12,725	1,628	5,050	6,840	24,796	27,011	24,446	26,852	7,512	8,213	6,947	2,293	2,597	985	785	0	0	0	-	-	-	-	-	-
Amortization of Intangible Assets
63,100	64,800	65,905	66,392	67,200	67,900	69,021	70,145	70,871	71,500	70,968	71,061	68,886	64,400	61,303	51,297	38,755	27,977	16,625	11,250	10,840	10,919	11,246	11,301	11,163	11,133	10,250	9,638	9,058	8,335	7,066	5,833	4,630	3,404	3,183	3,151	0	0	0
Asset impairment charges
91,745	92,400	22,433	22,433	22,433	21,778	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Grant repayment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	25,889	25,889	25,889	25,889	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total costs and expenses
1,130,446	1,175,987	1,151,046	1,166,542	1,161,707	1,161,463	1,168,211	1,178,737	1,228,376	1,242,448	1,168,832	1,196,685	1,207,087	1,214,045	1,253,173	1,082,772	821,776	590,219	364,078	280,795	271,387	236,940	235,513	207,190	190,564	176,162	150,564	132,077	109,825	84,313	80,706	68,136	56,897	51,168	30,366	29,904	0	0	0
Operating Income (Loss)
-239,496	-274,052	-251,603	-246,056	-203,904	-171,197	-238,814	-253,115	-273,838	-276,442	-192,487	-168,345	-114,248	-96,551	-30,810	-15,410	-69,085	-98,481	-122,998	-162,976	-172,452	-145,815	-149,229	-120,038	-103,136	-79,632	-53,478	-43,837	-35,195	-37,269	-36,031	-32,466	-27,900	-23,189	-18,936	-18,659	0	0	0
Other income and (expense), net:
Interest income
1,296	1,710	2,609	2,302	1,757	1,240	85	291	400	610	771	685	684	478	570	420	290	255	348	737	739	771	588	274	357	376	302	263	220	188	236	346	307	288	0	0	0	-	-
Interest expense
22,257	21,516	20,005	17,157	14,378	11,890	9,763	8,659	7,439	6,601	6,179	6,357	7,072	7,430	8,145	8,872	7,641	8,419	7,986	7,643	11,342	12,263	14,227	15,234	14,391	13,802	10,578	7,562	3,951	1,405	2,608	1,759	1,269	1,005	0	0	0	-	-
Fair value changes of derivative instruments, net
380	174	-440	-574	2,062	3,043	1,572	-5,823	-2,589	52	10,636	12,485	8,238	2,778	-10,872	27,073	9,282	-39,083	-48,631	-77,570	-50,047	-10,632	-3,352	-34,450	-32,766	-45,942	-38,782	-10,820	-23,448	1,218	0	0	0	-	-	-	-	-	-
Other income (expense), net
-24,590	-11,281	-28,485	-13,839	619	1,535	17,004	18,425	9,308	10,457	3,465	-104	6,399	3,903	-5,460	14,994	9,784	7,730	11,745	-8,501	-6,271	-3,088	34,112	29,089	34,126	34,782	2,765	10,607	2,314	164	439	-287	-150	-288	-1,077	-796	0	0	0
Other income and (expense), net
-45,171	-30,913	-46,321	-29,268	-9,940	-6,072	8,898	4,234	-320	4,518	8,693	6,709	8,249	-271	-23,907	33,615	11,715	-39,517	-44,524	-92,977	-66,921	-25,212	17,121	-20,321	-12,674	-24,586	-46,293	-7,512	-24,865	165	-487	-741	-192	-1,044	0	0	0	-	-
Loss before income taxes and investment losses
-284,667	-304,965	-297,924	-275,324	-213,844	-177,269	-229,916	-248,881	-274,158	-271,924	-183,794	-161,636	-105,999	-96,822	-54,717	18,205	-57,370	-137,998	-167,522	-255,953	-239,373	-171,027	-132,108	-140,359	-115,810	-104,218	-99,771	-51,349	-60,060	-37,104	-35,891	-32,877	-28,013	-24,233	-20,013	-19,455	0	0	0
Income tax provision
7,448	7,060	-24,652	-37,984	-37,051	-38,726	50,726	37,884	24,907	18,855	-73,798	-69,381	-42,553	-56,115	-51,083	-124,073	-139,690	-113,675	-88,203	5,069	4,919	24	423	1,419	2,243	1,672	-7,457	-8,875	-9,798	-9,626	-19,467	-19,366	-19,376	-19,358	281	362	0	0	0
Net loss before investment losses
-292,115	-312,025	-273,272	-237,340	-176,793	-138,543	-280,642	-286,765	-299,065	-290,779	-109,996	-92,255	-63,446	-40,707	-3,634	142,278	82,320	-24,323	-79,319	-261,022	-244,292	-171,051	-132,531	-141,778	-118,053	-105,890	-101,416	0	0	-	0	-	-	-	-	-	-	-	-
Loss from investments in investees
-1,180	-2,900	-5,373	-6,953	-13,895	-14,497	-14,242	-16,381	-14,796	-14,471	-14,277	-11,078	-7,438	-7,652	-6,185	-8,873	-7,689	-7,105	-7,168	-3,726	-3,292	-3,587	-6,081	-7,621	-9,622	-11,456	-8,457	-7,325	-5,429	-2,062	-1,880	-1,713	-1,689	-1,589	-1,383	-1,326	0	0	0
Loss from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-21,677	0	0	0	-
Income from discontinued operations, net of tax
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	5,181	-5,363	0	0	0	-
Loss before investment losses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-20,294	-19,817	0	0	0
Net loss
0	-	-278,645	-244,293	0	-	-294,884	-303,146	-313,861	-	-124,273	-103,333	-70,884	-48,359	-9,819	133,405	74,631	-31,428	-86,487	-264,748	-247,584	-174,638	-181,983	0	0	-	0	-	-	-29,540	0	0	0	-	-	-	-	-	-
Loss per share, basic and diluted:
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	-	-	-	-	-	-	-	-
Less: Net loss attributable to noncontrolling interests
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,400	-1,890	-3,235	-3,357	-2,972	-3,112	-2,570	-2,932	-2,939	-2,309	-1,506	0	-	0	0	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-114,407	-98,153	-47,801	-54,652	-29,048	-10,099	-8,689	-4,190	-1,283	-27,040	-25,019	0	0	0
Preferred stock dividend
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	420	980	1,540	2,100	2,240	2,199	2,239	2,294	2,379	2,516	2,577	0	0	0
Net loss attributable to common shareholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-30,028	-84,597	-261,513	-244,227	-171,666	-135,500	-146,829	-124,743	-114,827	-99,133	-49,341	-56,752	-31,288	-12,298	-10,928	-6,484	-3,662	-29,556	-27,596	0	0	0
Loss per share basic and diluted:
Loss from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.02	-	-
Loss from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	-	-
Loss per share (in dollars per share)
-0.09	-0.18	-0.11	-0.10	-0.14	-0.13	-0.05	-0.01	-0.08	-0.40	-0.06	-0.03	-0.06	-0.07	-0.03	0.03	-0.02	0.03	0.26	-0.09	-0.26	-0.13	-0.11	-0.06	-0.11	-0.03	-0.17	-0.01	-0.11	-0.01	-0.03	-0.04	-0.03	0.06	-0.03	-0.02	-0.02	-0.03	-0.03
Loss from continuing operations, per basic and diluted share
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.17	-	-	-	-0.03	-	-	-	-0.02	-0.02	-	-0.02	-
Income from discontinued operations, per basic and diluted share
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	-	-	-	0.00	-	-	-	-0.01	0.00	-	-	-
Weighted average common shares outstanding, basic and diluted (in shares)
640,578	622,771	586,351	586,351	586,344	573,773	559,786	559,541	559,473	-	559,405	-	558,434	-	552,229	-	545,823	-	-	-	446,480	-	-	413,339	412,909	410,079	360,638	336,732	312,932	289,516	298,103	297,836	297,543	-	285,582	285,135	-	255,252	255,252
Earnings Per Share, Diluted
-	-	-	-	-	-	-	-	-	-	-	-0.04	-	-	-	0.02	-	-	0.18	-0.09	-	-	-0.11	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average common shares outstanding, basic (in shares)
-	-	-	-	-	-	-	-	-	-	-	559,348	-	-	-	547,558	-	-	500,562	462,253	-	-	427,577	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average common shares outstanding, diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	564,163	-	-	-	557,040	-	-	515,512	462,253	-	-	427,577	-	-	-	-	-	-	-	-	-	-	-	-	-	261,042	-	-
Services
Total revenues
708,382	716,434	721,555	743,227	780,824	813,248	749,558	747,623	765,480	782,710	814,346	872,495	904,595	928,572	999,402	844,296	580,192	329,739	109,957	8,520	8,765	8,666	9,213	9,501	10,536	11,658	10,467	7,797	4,754	1,749	0	0	0	-	-	-	-	-	-
Cost of service revenue
504,190	511,206	521,787	532,786	537,116	546,654	551,079	548,935	558,428	558,953	566,051	569,402	566,472	564,103	548,993	467,109	328,643	193,305	43,491	-10,820	-760	9,372	922	10,515	11,053	10,419	45,662	41,197	34,648	27,878	23,186	19,716	18,052	17,243	16,433	17,266	0	0	0
Products
Total revenues
117,957	112,184	105,485	104,719	104,562	107,112	115,536	112,936	113,379	107,759	94,184	91,958	85,799	83,467	84,322	84,518	84,559	80,146	77,571	74,097	72,641	76,983	75,964	75,236	72,462	68,161	65,952	60,884	52,183	45,295	35,757	31,022	29,533	27,844	27,816	28,511	0	0	0
Cost of service revenue
64,493	61,278	57,947	55,983	57,490	57,982	60,644	63,142	60,995	61,177	56,788	53,307	52,270	47,379	46,319	44,351	43,812	41,934	39,409	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Transfer Of Intellectual Property And Other [Member]
Total revenues
64,611	73,317	72,403	72,540	72,417	69,906	64,303	65,063	75,679	75,537	67,815	63,887	102,445	105,455	138,639	138,548	87,940	81,853	53,552	35,202	17,529	5,476	1,107	2,415	4,430	16,711	15,680	14,572	12,706	0	0	0	0	-	-	-	-	-	-